stannous chloride
Small moleculeexperimental
Tin(II) chloride, also known as stannous chloride, is a white crystalline solid with the formula SnCl2. It forms a stable dihydrate, but aqueous solutions tend to undergo hydrolysis, particularly if hot. SnCl2 is widely used as a reducing agent (in acid solution), and in electrolytic baths for tin-plating. Tin(II) chloride should not be confused with the other chloride of tin; tin(IV) chloride or stannic chloride (SnCl4). — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 18, 2017 (NCT03310268)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTin(II) chloride ↗
Also known as
- sncl(2)
- stannous chloride
- stannous chloride
- stannous chloride
- stannous chloride, 113sn-labeled
- stannous chloride, 2h-labeled
- stannous chloride, 35cl-labeled
- stannous chloride anhydrous
- stannous chloride, dichlorostannate (-1)
- stannous chloride dihydrate
- tin chloride
- tin chloride
- tin chloride
- tin chloride (sncl2)
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03310268 | N/A | Nov 18, 2017 | GlaxoSmithKline |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2017 |
1 organizations
Page 1 / 1